Detalhe da pesquisa
1.
Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort.
Ann Allergy Asthma Immunol
; 129(4): 490-496, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835293
2.
Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD.
Respirology
; 24(12): 1183-1190, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31222861
3.
Statin use and exacerbations in individuals with chronic obstructive pulmonary disease.
Thorax
; 70(1): 33-40, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25349333
4.
Fibrinogen and α1-antitrypsin in COPD exacerbations.
Thorax
; 70(11): 1014-21, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26304913
5.
Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population.
J Gen Intern Med
; 30(1): 51-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25245885
6.
Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease.
Respirology
; 20(1): 101-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25297724
7.
Genetic influences on pulmonary function: a large sample twin study.
Lung
; 189(4): 323-30, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21660583
8.
Witnessed sleep apneas together with elevated plasma glucose are predictors of COPD exacerbations.
Eur Clin Respir J
; 7(1): 1765543, 2020 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33224452
9.
Prognosis of COPD depends on severity of exacerbation history: A population-based analysis.
Respir Med
; 155: 141-147, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362177
10.
Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition.
Respir Med
; 109(12): 1562-8, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26560643
11.
Characteristics of undertreatment in COPD in the general population.
Chest
; 144(6): 1811-1818, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23989916